0GQU.LSE Active Biotech AB

Healthcare Oil, Gas & Consumable Fuels London Exchange
0.0557 SEK
Close of Aug 28, 2026
3.20 8.60
Market cap
SEK 8.09M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2021.

Is 0GQU.LSE undervalued?

Graham number

The Graham number of Active Biotech AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Active Biotech AB fundamental analysis

No fundamental analysis for Active Biotech AB yet.

Active Biotech AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a …

Full company profile